Clinical Study of Universal CAR-γδT Cell Injection in the Treatment of Patients With Relapsed AML After Transplantation

NCT04796441 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

AML

Interventions

BIOLOGICAL: CAR-γδT

Sponsor

Hebei Senlang Biotechnology Inc., Ltd.